Patent details
EP3372617 Title: BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
Basic Information
- Publication number:
- EP3372617
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP181593245
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME
- French Title of Invention:
- PROTÉINES DE FUSION LIANTES, CONJUGUÉS PROTÉINES DE FUSION LIANTES-MÉDICAMENTS, CONJUGUÉS XTEN-MÉDICAMENTS ET PROCÉDÉS POUR LES PRÉPARER ET LES UTILISER
- German Title of Invention:
- BINDUNGSFUSIONSPROTEINE, BINDUNGSFUSIONSPROTEINARZNEIMITTELKONJUGATE, XTEN-ARZNEIMITTELKONJUGATE SOWIE VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 22/08/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/09/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 24/07/2024
- Unitary Effect Registration Date:
- 02/09/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 01/04/2011
- Grant date:
- 24/07/2024
- EP Publication Date:
- 12/09/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/07/2024
- EP B1 Publication Date:
- 24/07/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 01/04/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/07/2024
- Name:
- Amunix Pharmaceuticals, Inc.
- Address:
- 2 Tower Pl 1100, South San Francisco, CA 94080-1826, United States (US)
Inventor
1
- Name:
- Silverman, Joshua
- Address:
- United States (US)
2
- Name:
- Alters, Susan E.
- Address:
- United States (US)
3
- Name:
- Wang, Chia-wei
- Address:
- United States (US)
4
- Name:
- Stemmer, Willem P.
- Address:
- United States (US)
5
- Name:
- Schellenberger, Volker
- Address:
- United States (US)
6
- Name:
- Spink, Benjamin
- Address:
- United States (US)
Priority
1
- Priority Number:
- 341720 P
- Priority Date:
- 02/04/2010
- Priority Country:
- United States (US)
2
- Priority Number:
- 341996 P
- Priority Date:
- 08/04/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 19/00; C07K 16/28;
Publication
European Patent Bulletin
1
- Issue number:
- 202430
- Publication date:
- 24/07/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202432
- Publication date:
- 07/08/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202439
- Publication date:
- 25/09/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202440
- Publication date:
- 02/10/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|